Reference
Wang H, et al. Identification of a novel LRRC4C-ALK fusion in lung adenocarcinoma and outcome of the response to anaplastic lymphoma kinase inhibitors. Journal of Gene Medicine 23: No. 3, Mar 2021. Available from: URL: http://doi.org/10.1002/jgm.3316
Rights and permissions
About this article
Cite this article
Alectinib/ceritinib/crizotinib. Reactions Weekly 1849, 25 (2021). https://doi.org/10.1007/s40278-021-93409-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-93409-8